DNA alterations may predict treatment response in chronic myelomonocytic leukemia patients
Brightsurf Science News and Current Events,
Chronic myelomonocytic leukemia (CMML) is a relatively rare cancer of the blood that primarily affects adults.
Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia
Overview of attention for article published in Journal of Clinical Investigation, March 2015
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (96th percentile)
-
High Attention Score compared to outputs of the same age and source (86th percentile)
Mentioned by
- news
- 5 news outlets
- blogs
- 1 blog
- 4 X users
- patent
- 3 patents
- guideline
- 1 clinical guideline source
Readers on
- mendeley
- 149 Mendeley